Bottom line
How much do FBIOX and RYOIX overlap?
53% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 37.8% of FBIOX's assets and 36.7% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.
FBIOX holds far more positions (215 vs 74), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FBIOX and RYOIX have in common
| Holding | % of FBIOX | % of RYOIX | Overlap |
|---|---|---|---|
| Abbvie Inc | 9.22% | 8.17% | 8.17% |
| Amgen Inc | 6.53% | 5.05% | 5.05% |
| Gilead Sciences Inc | 4.82% | 4.49% | 4.49% |
| Alnylam Pharmaceuticals Inc | 2.93% | 2.36% | 2.36% |
| Insmed Inc | 2.25% | 1.79% | 1.79% |
| Argenx Se | 2.25% | 1.48% | 1.48% |
| Revolution Medicines Inc | 2.02% | 2.48% | 2.02% |
| Jazz Pharmaceuticals Plc | 1.84% | 1.42% | 1.42% |
| Natera Inc | 1.41% | 2.12% | 1.41% |
| Moderna Inc | 1.28% | 2.15% | 1.28% |
| Biogen Inc | 1.26% | 2.13% | 1.26% |
| Roivant Sciences Ltd | 1.13% | 1.66% | 1.13% |
| Bridgebio Pharma Inc | 0.89% | 1.38% | 0.89% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FBIOX
- Krystal Biotech Inc — 10.58%
- Fidelity Revere Street Trust — 3.35%
- Praxis Precision Medicines Inc. — 2.47%
- Ascendis Pharma A/s — 2.04%
- Ucb Sa — 2.00%
- Scholar Rock Holding Corp — 1.55%
- Axsome Therapeutics Inc — 1.28%
- Protagonist Therapeutics Inc — 1.15%
- Cogent Biosciences Inc — 1.07%
- Tango Therapeutics Inc — 0.98%
- Celcuity Inc — 0.95%
- Madrigal Pharmaceuticals Inc — 0.93%
Only in RYOIX
- Vertex Pharmaceuticals Inc — 4.32%
- Regeneron Pharmaceuticals Inc — 2.93%
- Beone Medicines Ltd — 2.17%
- Royalty Pharma Plc — 2.01%
- Illumina Inc — 1.94%
- United Therapeutics Corp — 1.72%
- Guardant Health Inc — 1.72%
- Incyte Corp — 1.62%
- Viatris Inc — 1.55%
- Neurocrine Biosciences Inc — 1.52%
- Ionis Pharmaceuticals Inc — 1.35%
- Cytokinetics Inc — 1.35%
Asset mix
| Asset type | FBIOX | RYOIX |
|---|---|---|
| Stocks | 99.0% | 99.6% |
| Cash & short-term funds | 3.5% | 0.6% |
| Preferred stock | 0.9% | — |
| Repurchase agreements | — | 0.6% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Country mix
| Country | FBIOX | RYOIX |
|---|---|---|
| US | 88.5% | 85.8% |
| CH | 1.1% | 3.3% |
| GB | 0.8% | 3.2% |
| NL | 2.9% | 1.5% |
| IE | 2.0% | 2.7% |
| DK | 2.6% | 0.9% |
| BE | 2.0% | — |
| BM | 1.1% | 1.7% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do FBIOX and RYOIX overlap?
What stocks do FBIOX and RYOIX have in common?
Should I own both FBIOX and RYOIX?
Which holds more stocks, FBIOX or RYOIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.